KALA BIO, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
19.3M
on 2026-06-30, from 56K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-50 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
$250.0M
H.C. Wainwright, agreement of 2026-07-22. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-Q filed 2026-08-19 is not read yet.
Cash
1.5 quarters
$7.2M on 2026-06-30 ÷ $5.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-12-11 | Private placement | 2,100,000 | not read | $4.2M | 8-K ↗ |
| 2025-12-04 | Registered direct offering incl. 9.10M pre-funded | 10,000,000 | $1.00 | $10.0M | 424B5 ↗ |
| 2025-11-25 | Private placement | not read | not read | $6.0M | 8-K ↗ |
| 2024-12-29 | Private placement | not read | not read | $10.8M | 8-K ↗ |
Also on file: a 1-for-2 reverse split, 2026-01-30 8-K ↗ · a 1-for-50 reverse split, 2026-05-07 8-K ↗